Predicting disease progression in cystic fibrosis

References

• Elborn JS. Cystic fibrosis. Lancet. 2016 Nov 19;388(10059):2519–2531. PubMed PMID: 27140670.
   PubMed Web of Science ®Google Scholar
• Stoltz DA, Meyerholz DK, Welsh MJ. Origins of cystic fibrosis lung disease. N Engl J Med. 2015 Jan 22;372(4):351–362. PubMed PMID: 25607428; PubMed Central PMCID: PMCPMC4916857.
   PubMed Web of Science ®Google Scholar
• Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992 Apr 30;326(18):1187–1191. PubMed PMID: 1285737. .
   PubMed Web of Science ®Google Scholar
• Augarten A, Akons H, Aviram M, et al. Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplant. 2001 Oct;5(5):339–342. PubMed PMID: 11560752
   PubMed Web of Science ®Google Scholar
• Rosenbluth DB, Wilson K, Ferkol T, et al. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest. 2004 Aug;126(2):412–419. PubMed PMID: 15302726. .
   PubMed Web of Science ®Google Scholar
• Vilozni D, Lavie M, Sarouk I, et al. Progressive flow-to-volume dysanapsis in cystic fibrosis: a predictor for lung transplantation? Am J Respir Crit Care Med. 2012 Jul 1;186(1):82–87. PubMed PMID: 22538801. .
   PubMed Web of Science ®Google Scholar
• Konstan MW, Wagener JS, VanDevanter DR. Characterizing aggressiveness and predicting future progression of CF lung disease. J Cyst Fibros. 2009 Jun;8(Suppl 1):S15–9. PubMed PMID: 19460682; PubMed Central PMCID: PMCPMC4167362.
   PubMedGoogle Scholar
• Schluchter MD, Konstan MW, Drumm ML, et al. Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. Am J Respir Crit Care Med. 2006 Oct 1;174(7):780–786. PubMed PMID: 16858011; PubMed Central PMCID: PMCPMC2648062.
   PubMed Web of Science ®Google Scholar
• Cystic Fibrosis Foundation Patient Registry Annual Data Report 2016. cited 2018 Apr 20. Available from: https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2016-Patient-Registry-Annual-Data-Report.pdf].
   Google Scholar
• Gustafsson PM, De Jong PA, Tiddens HA, et al. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax. 2008 Feb;63(2):129–134. PubMed PMID: 17675316. .
   PubMed Web of Science ®Google Scholar
• Judge EP, Dodd JD, Masterson JB, et al. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis. Chest. 2006 Nov;130(5):1424–1432. PubMed PMID: 17099020.
   PubMed Web of Science ®Google Scholar
• Rosenthal M. How good are pulmonary function tests as an indicator of short and long term health status? Pediatr Pulmonol. 2009;S32:171–172.
   Google Scholar
• Tiddens HA. Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol. 2002 Sep;34(3):228–231. PubMed PMID: 12203854.
   PubMed Web of Science ®Google Scholar
• Brody AS, Tiddens HA, Castile RG, et al. Computed tomography in the evaluation of cystic fibrosis lung disease. Am J Respir Crit Care Med. 2005 Nov 15;172(10):1246–1252. PubMed PMID: 16100011.
   PubMed Web of Science ®Google Scholar
• Fuchs SI, Gappa M, Eder J, et al. Tracking Lung clearance index and chest CT in mild cystic fibrosis lung disease over a period of three years. Respir Med. 2014 Jun;108(6):865–874. PubMed PMID: 24726097.
   PubMed Web of Science ®Google Scholar
• Sly PD, Gangell CL, Chen L, et al. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med. 2013 May 23;368(21):1963–1970. PubMed PMID: 23692169. .
   PubMed Web of Science ®Google Scholar
• Steinkamp G, Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax. 2002 Jul;57(7):596–601. PubMed PMID: 12096202; PubMed Central PMCID: PMCPMC1746376.
   PubMed Web of Science ®Google Scholar
• McKone EF, Emerson SS, Edwards KL, et al. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet. 2003 May 17;361(9370):1671–1676. PubMed PMID: 12767731.
   PubMed Web of Science ®Google Scholar
• Rosenfeld M, Davis R, FitzSimmons S, et al. Gender gap in cystic fibrosis mortality. Am J Epidemiol. 1997 May 1;145(9):794–803. PubMed PMID: 9143209. .
   PubMed Web of Science ®Google Scholar
• Moran A, Dunitz J, Nathan B, et al. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009 Sep;32(9):1626–1631. PubMed PMID: 19542209; PubMed Central PMCID: PMCPMC2732133.
   PubMed Web of Science ®Google Scholar
• Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):891–895. PubMed PMID: 10988101.
   PubMed Web of Science ®Google Scholar
• Ledson MJ, Gallagher MJ, Jackson M, et al. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax. 2002 Feb;57(2):142–145. PubMed PMID: 11828044; PubMed Central PMCID: PMCPMC1746259
   PubMed Web of Science ®Google Scholar
• McKone EF, Goss CH, Aitken ML. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest. 2006 Nov;130(5):1441–1447. PubMed PMID: 17099022.
   PubMed Web of Science ®Google Scholar
• Shwachman H, Kulczycki LL. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child. 1958 Jul;96(1):6–15. PubMed PMID: 13544726. .
   PubMedGoogle Scholar
• Milla CE, Warwick WJ. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest. 1998 May;113(5):1230–1234. PubMed PMID: 9596299.
   PubMed Web of Science ®Google Scholar
• Harun SN, Wainwright C, Klein K, et al. A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis. Paediatr Respir Rev. 2016 Sep;20:55–66. PubMed PMID: 27259460.
   PubMed Web of Science ®Google Scholar
• Konstan MW, Morgan WJ, Butler SM, et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr. 2007 Aug;151(2):134–139, 139 e1. PubMed PMID: 17643762.
   PubMed Web of Science ®Google Scholar
• Szczesniak RD, Li D, Su W, et al. Phenotypes of rapid cystic fibrosis lung disease progression during adolescence and young adulthood. Am J Respir Crit Care Med. 2017 Aug 15;196(4):471–478. PubMed PMID: 28410569; PubMed Central PMCID: PMCPMC5564675.
   PubMed Web of Science ®Google Scholar
• Rosenfeld M, VanDevanter DR, Ren CL, et al. Decline in lung function does not predict future decline in lung function in cystic fibrosis patients. Pediatr Pulmonol. 2015 Sep;50(9):856–862. PubMed PMID: 26086901.
   PubMed Web of Science ®Google Scholar
• Aurora P, Gustafsson P, Bush A, et al. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax. 2004 Dec;59(12):1068–1073. PubMed PMID: 15563707; PubMed Central PMCID: PMCPMC1746917. .
   PubMed Web of Science ®Google Scholar
• VanDevanter DR, Wagener JS, Pasta DJ, et al. Pulmonary outcome prediction (POP) tools for cystic fibrosis patients. Pediatr Pulmonol. 2010 Dec;45(12):1156–1166. PubMed PMID: 20717915; PubMed Central PMCID: PMCPMC4112577.
   PubMed Web of Science ®Google Scholar
• De Jong PA, Nakano Y, Lequin MH, et al. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J. 2004 Jan;23(1):93–97. PubMed PMID: 14738238. .
   PubMed Web of Science ®Google Scholar
• Gustafsson PM, Aurora P, Lindblad A. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J. 2003 Dec;22(6):972–979. PubMed PMID: 14680088.
   PubMed Web of Science ®Google Scholar
• Kraemer R, Blum A, Schibler A, et al. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med. 2005 Feb 15;171(4):371–378. PubMed PMID: 15531750.
   PubMed Web of Science ®Google Scholar
• Horsley AR, Gustafsson PM, Macleod KA, et al. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax. 2008 Feb;63(2):135–140. PubMed PMID: 17675315.
   PubMed Web of Science ®Google Scholar
• Ramsey KA, Rosenow T, Turkovic L, et al. Lung clearance index and structural lung disease on computed tomography in early cystic fibrosis. Am J Respir Crit Care Med. 2016 Jan 1;193(1):60–67. PubMed PMID: 26359952.
   PubMed Web of Science ®Google Scholar
• Owens CM, Aurora P, Stanojevic S, et al. Lung clearance index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax. 2011 Jun;66(6):481–488. PubMed PMID: 21422040.
   PubMed Web of Science ®Google Scholar
• Aurora P, Stanojevic S, Wade A, et al. Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med. 2011 Mar 15;183(6):752–758. PubMed PMID: 20935113. .
   PubMed Web of Science ®Google Scholar
• Stanojevic S, Davis SD, Retsch-Bogart G, et al. Progression of lung disease in preschool patients with cystic fibrosis. Am J Respir Crit Care Med. 2017 May 1;195(9):1216–1225. PubMed PMID: 27943680; PubMed Central PMCID: PMCPMC5439018.
   PubMed Web of Science ®Google Scholar
• Stanojevic S, Ratjen F. Physiologic endpoints for clinical studies for cystic fibrosis. J Cyst Fibros. 2016 Jul;15(4):416–423. . PubMed PMID: 27316663.
   PubMed Web of Science ®Google Scholar
• Tiddens HA, Puderbach M, Venegas JG, et al. Novel outcome measures for clinical trials in cystic fibrosis. Pediatr Pulmonol. 2014 Dec 30. DOI: 10.1002/ppul.23146. PubMed PMID: 25641878; PubMed Central PMCID: PMCPMC4365726.
   Google Scholar
• Davies J, Sheridan H, Bell N, et al. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial. Lancet Respir Med. 2013 Oct;1(8):630–638. PubMed PMID: 24461666.
   PubMed Web of Science ®Google Scholar
• Ratjen F, Hug C, Marigowda G, et al. Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial. Lancet Respir Med. 2017 Jul;5(7):557–567. PubMed PMID: 28606620.
   PubMed Web of Science ®Google Scholar
• Chen DL, Ferkol TW, Mintun MA, et al. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am J Respir Crit Care Med. 2006 Jun 15;173(12):1363–1369. PubMed PMID: 16543553; PubMed Central PMCID: PMCPMC2662975.
   PubMed Web of Science ®Google Scholar
• Klein M, Cohen-Cymberknoh M, Armoni S, et al. 18F-fluorodeoxyglucose-PET/CT imaging of lungs in patients with cystic fibrosis. Chest. 2009 Nov;136(5):1220–1228. PubMed PMID: 19696124.
   PubMed Web of Science ®Google Scholar
• Amin R, Charron M, Grinblat L, et al. Cystic fibrosis: detecting changes in airway inflammation with FDG PET/CT. Radiology. 2012 Sep;264(3):868–875. PubMed PMID: 22829680.
   PubMed Web of Science ®Google Scholar
• Ciet P, Bertolo S, Ros M, et al. Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging. Eur Respir J. 2017 Jul;50(1). DOI: 10.1183/13993003.01437-2016. PubMed PMID: 28729470.
   Web of Science ®Google Scholar
• Stahl M, Wielputz MO, Graeber SY, et al. Comparison of Lung clearance index and magnetic resonance imaging for assessment of lung disease in children with cystic fibrosis. Am J Respir Crit Care Med. 2017 Feb 1;195(3):349–359. PubMed PMID: 27575911.
   PubMed Web of Science ®Google Scholar
• Taussig LM, Kattwinkel J, Friedewald WT, et al. A new prognostic score and clinical evaluation system for cystic fibrosis. J Pediatr. 1973 Mar;82(3):380–390. PubMed PMID: 4698929. .
   PubMed Web of Science ®Google Scholar
• Brasfield D, Hicks G, Soong S, et al. The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics. 1979 Jan;63(1):24–29. PubMed PMID: 440798
   PubMed Web of Science ®Google Scholar
• Brody AS, Klein JS, Molina PL, et al. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr. 2004 Jul;145(1):32–38. PubMed PMID: 15238903.
   PubMed Web of Science ®Google Scholar
• Tepper LA, Utens EM, Caudri D, et al. Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis. Eur Respir J. 2013 Aug;42(2):371–379. PubMed PMID: 23314900.
   PubMed Web of Science ®Google Scholar
• Sanders DB, Li Z, Brody AS, et al. Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis. Am J Respir Crit Care Med. 2011 Oct 1;184(7):816–821. PubMed PMID: 21737586; PubMed Central PMCID: PMCPMC3208650. .
   PubMed Web of Science ®Google Scholar
• Brody AS, Sucharew H, Campbell JD, et al. Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med. 2005 Nov 1;172(9):1128–1132. PubMed PMID: 16100015.
   PubMed Web of Science ®Google Scholar
• Bortoluzzi CF, Volpi S, D’Orazio C, et al. Bronchiectases at early chest computed tomography in children with cystic fibrosis are associated with increased risk of subsequent pulmonary exacerbations and chronic pseudomonas infection. J Cyst Fibros. 2014 Sep;13(5):564–571. PubMed PMID: 24726420.
   PubMed Web of Science ®Google Scholar
• Sanders DB, Li Z, Brody AS. Chest computed tomography predicts the frequency of pulmonary exacerbations in children with cystic fibrosis. Ann Am Thorac Soc. 2015 Jan;12(1):64–69. PubMed PMID: 25474182; PubMed Central PMCID: PMCPMC5466157.
   PubMed Web of Science ®Google Scholar
• Loeve M, Gerbrands K, Hop WC, et al. Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis. Chest. 2011 Jul;140(1):178–185. PubMed PMID: 21148242.
   PubMed Web of Science ®Google Scholar
• Mott LS, Park J, Murray CP, et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax. 2012 Jun;67(6):509–516. PubMed PMID: 22201161.
   PubMed Web of Science ®Google Scholar
• Turkovic L, Caudri D, Rosenow T, et al. Structural determinants of long term functional outcomes in children with cystic fibrosis. Am J Resp Crit Care. 2017;195:55. PubMed PMID: WOS:000400372504484. English.
   Web of Science ®Google Scholar
• Loeve M, Hop WC, de Bruijne M, et al. Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med. 2012 May 15;185(10):1096–1103. PubMed PMID: 22403801. .
   PubMed Web of Science ®Google Scholar
• Belle-van Meerkerk G, de Jong PA, de Valk HW, et al. Pretransplant HRCT characteristics are associated with worse outcome of lung transplantation for cystic fibrosis patients. PLoS One. 2015;10(12):e0145597. PubMed PMID: 26698308; PubMed Central PMCID: PMCPMC4689402
   PubMed Web of Science ®Google Scholar
• de Jong PA, Lindblad A, Rubin L, et al. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax. 2006 Jan;61(1):80–85. PubMed PMID: 16244089; PubMed Central PMCID: PMCPMC2080716.
   PubMed Web of Science ®Google Scholar
• Loeve M, Krestin GP, Rosenfeld M, et al. Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease? Eur Respir J. 2013 Sep;42(3):844–857. PubMed PMID: 23258780.
   PubMed Web of Science ®Google Scholar
• DeBoer EM, Swiercz W, Heltshe SL, et al. Automated CT scan scores of bronchiectasis and air trapping in cystic fibrosis. Chest. 2014 Mar 1;145(3):593–603. PubMed PMID: 24114359; PubMed Central PMCID: PMCPMC3941250.
   PubMed Web of Science ®Google Scholar
• Ohno Y, Koyama H, Yoshikawa T, et al. Pulmonary magnetic resonance imaging for airway diseases. J Thorac Imaging. 2011 Nov;26(4):301–316. PubMed PMID: 22009083.
   PubMed Web of Science ®Google Scholar
• Renz DM, Scholz O, Bottcher J, et al. Comparison between magnetic resonance imaging and computed tomography of the lung in patients with cystic fibrosis with regard to clinical, laboratory, and pulmonary functional parameters. Invest Radiol. 2015 Oct;50(10):733–742. PubMed PMID: 26154442.
   PubMed Web of Science ®Google Scholar
• Sileo C, Corvol H, Boelle PY, et al. HRCT and MRI of the lung in children with cystic fibrosis: comparison of different scoring systems. J Cyst Fibros. 2014 Mar;13(2):198–204. PubMed PMID: 24095209.
   PubMed Web of Science ®Google Scholar
• Wielputz MO, Puderbach M, Kopp-Schneider A, et al. Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med. 2014 Apr 15;189(8):956–965. PubMed PMID: 24564281.
   PubMed Web of Science ®Google Scholar
• Ciet P, Serra G, Andrinopoulou ER, et al. Diffusion weighted imaging in cystic fibrosis disease: beyond morphological imaging. Eur Radiol. 2016 Nov;26(11):3830–3839. PubMed PMID: 26873494.
   PubMed Web of Science ®Google Scholar
• Marshall H, Horsley A, Taylor CJ, et al. Detection of early subclinical lung disease in children with cystic fibrosis by lung ventilation imaging with hyperpolarised gas MRI. Thorax. 2017 Aug;72(8):760–762. PubMed PMID: 28265032.
   PubMed Web of Science ®Google Scholar
• McMahon CJ, Dodd JD, Hill C, et al. Hyperpolarized 3helium magnetic resonance ventilation imaging of the lung in cystic fibrosis: comparison with high resolution CT and spirometry. Eur Radiol. 2006 Nov;16(11):2483–2490. PubMed PMID: 16871384.
   PubMed Web of Science ®Google Scholar
• Ranganathan SC, Parsons F, Gangell C, et al. Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis. Thorax. 2011 May;66(5):408–413. PubMed PMID: 21398685.
   PubMed Web of Science ®Google Scholar
• Dakin CJ, Numa AH, Wang H, et al. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med. 2002 Apr 1;165(7):904–910. PubMed PMID: 11934712.
   PubMed Web of Science ®Google Scholar
• Sagel SD, Wagner BD, Anthony MM, et al. Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis. Am J Respir Crit Care Med. 2012 Nov 1;186(9):857–865. PubMed PMID: 22904182; PubMed Central PMCID: PMCPMC3530222. .
   PubMed Web of Science ®Google Scholar
• Liou TG, Adler FR, Keogh RH, et al. Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis. PLoS One. 2012;7(8):e42748. PubMed PMID: 22916155; PubMed Central PMCID: PMCPMC3416785
   PubMed Web of Science ®Google Scholar
• Colombo C, Faelli N, Tirelli AS, et al. Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis. Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2):423–432. PubMed PMID: 21658316.
   PubMed Web of Science ®Google Scholar
• Mayer-Hamblett N, Aitken ML, Accurso FJ, et al. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am J Respir Crit Care Med. 2007 Apr 15;175(8):822–828. PubMed PMID: 17234902; PubMed Central PMCID: PMCPMC2720115.
   PubMed Web of Science ®Google Scholar
• Esther CR Jr., Turkovic L, Rosenow T, et al. Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis. Eur Respir J. 2016 Dec;48(6):1612–1621. PubMed PMID: 27836957; PubMed Central PMCID: PMCPMC5766264.
   PubMed Web of Science ®Google Scholar
• Esther CR Jr., Olsen BM, Lin FC, et al. Exhaled breath condensate adenosine tracks lung function changes in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol. 2013 Apr 1;304(7):L504–9. PubMed PMID: 23355385; PubMed Central PMCID: PMCPMC3627937.
   PubMed Web of Science ®Google Scholar
• Shoki AH, Mayer-Hamblett N, Wilcox PG, et al. Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations. Chest. 2013 Nov;144(5):1659–1670. PubMed PMID: 23868694.
   PubMed Web of Science ®Google Scholar
• Ratjen F, Saiman L, Mayer-Hamblett N, et al. Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with pseudomonas aeruginosa. Chest. 2012 Nov;142(5):1259–1266. PubMed PMID: 22595153; PubMed Central PMCID: PMCPMC3610595.
   PubMed Web of Science ®Google Scholar
• Quon BS, Ngan DA, Wilcox PG, et al. Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis. PLoS One. 2014;9(2):e89341. PubMed PMID: 24586701; PubMed Central PMCID: PMCPMC3930718
   PubMed Web of Science ®Google Scholar
• Lindberg U, Carlsson M, Lofdahl CG, et al. BPI-ANCA and long-term prognosis among 46 adult CF patients: a prospective 10-year follow-up study. Clin Dev Immunol. 2012;2012:370107. PubMed PMID: 23346184; PubMed Central PMCID: PMCPMC3546553
   PubMedGoogle Scholar
• Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970–1989. Am J Epidemiol. 1996 May 15;143(10):1007–1017. PubMed PMID: 8629607.
   PubMed Web of Science ®Google Scholar
• MacKenzie T, Gifford AH, Sabadosa KA, et al. Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the cystic fibrosis foundation patient registry. Ann Intern Med. 2014 Aug 19;161(4):233–241. PubMed PMID: 25133359; PubMed Central PMCID: PMCPMC4687404.
   PubMed Web of Science ®Google Scholar
• Peterson ML, Jacobs DR Jr., Milla CE. Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis. Pediatrics. 2003 Sep;112(3 Pt 1):588–592. PubMed PMID: 12949289.
   PubMed Web of Science ®Google Scholar
• Li Z, Kosorok MR, Farrell PM, et al. Longitudinal development of mucoid pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA. 2005 Feb 2;293(5):581–588. PubMed PMID: 15687313.
   PubMed Web of Science ®Google Scholar
• Courtney JM, Bradley J, McCaughan J, et al. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol. 2007 Jun;42(6):525–532. PubMed PMID: 17469153.
   PubMed Web of Science ®Google Scholar
• Olivier KN, Weber DJ, Lee JH, et al. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med. 2003 Mar 15;167(6):835–840. PubMed PMID: 12433669.
   PubMed Web of Science ®Google Scholar
• Courtney JM, Dunbar KE, McDowell A, et al. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. J Cyst Fibros. 2004 Jun;3(2):93–98. PubMed PMID: 15463892.
   PubMedGoogle Scholar
• Sanders DB, Bittner RC, Rosenfeld M, et al. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol. 2011 Apr;46(4):393–400. PubMed PMID: 20967845.
   PubMed Web of Science ®Google Scholar
• McKone EF, Velentgas P, Swenson AJ, et al. Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype. J Cyst Fibros. 2015 Sep;14(5):580–586. PubMed PMID: 25660278.
   PubMed Web of Science ®Google Scholar
• Caudri D, Zitter D, Bronsveld I, et al. Is sweat chloride predictive of severity of cystic fibrosis lung disease assessed by chest computed tomography? Pediatr Pulmonol. 2017 Sep;52(9):1135–1141. PubMed PMID: 28586522.
   PubMed Web of Science ®Google Scholar
• Sockrider MM, Swank PR, Seilheimer DK, et al. Measuring clinical status in cystic fibrosis: internal validity and reliability of a modified NIH score. Pediatr Pulmonol. 1994 Feb;17(2):86–96. PubMed PMID: 8165043
   PubMed Web of Science ®Google Scholar
• Hayllar KM, Williams SG, Wise AE, et al. A prognostic model for the prediction of survival in cystic fibrosis. Thorax. 1997 Apr;52(4):313–317. PubMed PMID: 9196511; PubMed Central PMCID: PMCPMC1758530
   PubMed Web of Science ®Google Scholar
• Liou TG, Adler FR, Fitzsimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol. 2001 Feb 15;153(4):345–352. PubMed PMID: 11207152; PubMed Central PMCID: PMCPMC2198936. .
   PubMed Web of Science ®Google Scholar
• Mayer-Hamblett N, Rosenfeld M, Emerson J, et al. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med. 2002 Dec 15;166(12 Pt 1):1550–1555. PubMed PMID: 12406843.
   PubMed Web of Science ®Google Scholar
• McCarthy C, Dimitrov BD, Meurling IJ, et al. The CF-ABLE score: a novel clinical prediction rule for prognosis in patients with cystic fibrosis. Chest. 2013 May;143(5):1358–1364. PubMed PMID: 23172242.
   PubMed Web of Science ®Google Scholar
• Nkam L, Lambert J, Latouche A, et al. A 3-year prognostic score for adults with cystic fibrosis. J Cyst Fibros. 2017 Nov;16(6):702–708. PubMed PMID: 28330773.
   PubMed Web of Science ®Google Scholar
• Aaron SD, Stephenson AL, Cameron DW, et al. A statistical model to predict one-year risk of death in patients with cystic fibrosis. J Clin Epidemiol. 2015 Nov;68(11):1336–1345. PubMed PMID: 25655532.
   PubMed Web of Science ®Google Scholar
• Adler FR, Liou TG. The dynamics of disease progression in cystic fibrosis. PLoS One. 2016;11(6):e0156752. PubMed PMID: 27248696; PubMed Central PMCID: PMCPMC4889102.
   PubMed Web of Science ®Google Scholar
• Caudri D, Turkovic L, De Klerk N, et al. Predicting the development of bronchiectasis in preschool children with cystic fibrosis. Am J Resp Crit Care. 2016;193:168. PubMed PMID: WOS:000390749605242. English.
   Web of Science ®Google Scholar
• Szczesniak R, Heltshe SL, Stanojevic S, et al. Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher. J Cyst Fibros. 2017 May;16(3):318–326. PubMed PMID: 28117136; PubMed Central PMCID: PMCPMC5420487.
   PubMed Web of Science ®Google Scholar
• Buzzetti R, Alicandro G, Minicucci L, et al. Validation of a predictive survival model in Italian patients with cystic fibrosis. J Cyst Fibros. 2012 Jan;11(1):24–29. PubMed PMID: 21945182.
   PubMed Web of Science ®Google Scholar
• Buzzetti R, Salvatore D, Baldo E, et al. An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros. 2009 Jul;8(4):229–237. PubMed PMID: 19419909.
   PubMed Web of Science ®Google Scholar
• Ratjen F, Klingel M, Black P, et al. Changes in Lung clearance index in preschool cystic fibrosis patients treated with ivacaftor. Am J Respir Crit Care Med. 2018 Apr 3. DOI: 10.1164/rccm.201802-0243LE. [PubMed PMID: 29614238].
   Web of Science ®Google Scholar
• Breuer O, Caudri D, Akesson L, et al. The clinical significance of oropharyngeal cultures in young children with cystic fibrosis. Eur Respir J. 2018 Apr 20. DOI: 10.1183/13993003.00238-2018. [ PubMed PMID: 29678944].
   PubMed Web of Science ®Google Scholar